Forty Seven

Last updated: January 07, 2024

Irving L. Weissman, founder
Irving L. Weissman, founder
Country: USA | Funding: $156M (+)

Website: https://www.fortyseven.io/

With a passion for pioneering breakthrough solutions, we are committed to the advancement of immuno-oncology through the engagement of new and complementary phagocytic pathways that enhance anti-tumor efficacy and selectivity. Acquired by Gilead Sciences